Study summary

The main objective of the study is to evaluate whether the extended duration fidaxomicin therapy is superior to the standard vancomycin therapy in sustained clinical cure of CDI at 30 days after end of treatment (Day 40 or Day 55).

Additional Study Details

Phase
4
Product
  • Fidaxomicin
  • Vancomycin
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    364
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Phase IIIB/IV study to compare the efficacy of vancomycin therapy to extended duration of fidaxomicin therapy in the clinical cure of clostridium difficile infection (CDI) in an older population? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Site PL48006
      Bydgoszcz, Poland, 80-094
      Completed
      Site DE49008
      Marburg, Germany, 35043
      Completed
      Site GR30009
      Athens, Greece, 12461
      Completed
      Site FI35801
      Helsinki, Finland, 00029
      Completed
      Site PT35106
      Cotter, Portugal, 4835-044
      Completed
      Site HU36008
      Orosháza, Hungary, H-5900
      Completed
      Site HU36007
      Pecs, Hungary, H-7624
      Completed
      Site IT39004
      Milano, Italy, 20122
      Completed
      Site HR38506
      Osijek, Croatia, 31000
      Completed
      Site DE49012
      Hamburg, Germany, 25599
      Completed
      Site DK45004
      Nykøbing Falster, Denmark, 4800
      Completed
      Site RO40003
      Cluj-Napoca, Romania, 400348
      Completed
      Site GB44003
      Sutton in Ashfield, Nottinghamshire, United Kingdom, NG17 4JL
      Completed
      Site FR33008
      Clermont- Ferrand Cedex 1, France, 63003
      Completed
      Site GR30006
      Larisa, Greece, 41221
      Completed
      Site HU36006
      Gyula, Hungary, H-5700
      Completed
      Site RO40001
      Bucharest, Romania, 21105
      Withdrawn
      Site DE49017
      München, Germany, 80336
      Completed
      Site HU36005
      Mosonmagyarovar, Hungary, H-9200
      Completed
      Site HU36009
      Budapest, Hungary, 1088
      Completed
      Site CZ42001
      Praha 8 - Libeň, Czech Republic, 18081
      Completed
      Site HU36010
      Budapest, Hungary, 1082
      Completed
      Site DK45001
      Herlev, Denmark, 2730
      Completed
      Site GR30008
      Athens, Greece, 115 25
      Withdrawn
      Site PL48010
      Lodz, Poland, 90-153
      Completed
      Site BE32008
      Liege, Belgium, 4000
      Withdrawn
      Site DK45003
      Aarhus N, Denmark, 8200
      Completed
      Site DE49001
      Koeln, Germany, 50937
      Completed
      Site IT39009
      Firenze, Italy, 50134
      Completed
      Site BE32005
      Brussels, Belgium, B-1020
      Completed
      Site PL48002
      Warsaw, Poland, 02-781
      Completed
      Site GB44010
      London, United Kingdom, E1 1BB
      Completed
      Site PL48008
      Warsaw, Poland, 02-507
      Completed
      Site TR90001
      Antalya, Turkey, 07059
      Completed
      Site BE32007
      Aalst, Belgium, 9300
      Completed
      Site FR33004
      Nimes, France, 30000
      Completed
      Site BE32006
      Brugge, Belgium, B-8000
      Completed
      Site GB44005
      Cardiff, United Kingdom, CF14 4XW
      Completed
      Site FR33006
      Lille Cedex, France, 59037
      Withdrawn
      Site DE49009
      Jena, Germany, 07747
      Completed
      Site FR33009
      Saint-Priest en Jarez, France, 42270
      Completed
      Site RU70003
      Moscow, Russian Federation, 123423
      Withdrawn
      Site GB44011
      Whythenshawe, Manchester, United Kingdom, M23 9LT
      Completed
      Site IT39001
      Pisa, Italy, 56124
      Completed
      Site DK45005
      Hillerod, Denmark, 3400
      Completed
      Site FR33005
      Nantes, France, 44000
      Completed
      Site SI38605
      Ljubljana, Slovenia, 1000
      Completed
      Site FR33002
      Rennes, France, 35037
      Completed
      Site GB44009
      Truro, United Kingdom, TR1 3LJ
      Completed
      Site ES34005
      Madrid, Madrid, Spain, 28040
      Completed
      Site SE46002
      Göteborg, Sweden, 41685
      Completed
      Site PL48012
      Lodz, PL, Poland, 91-347
      Completed
      Site IT39003
      Monza, Italy, 20900
      Completed
      Site PT35101
      Almada, Portugal, 2800-525
      Completed
      Site HR38501
      Zagreb, Croatia, 10000
      Withdrawn
      Site DE49007
      Bonn, Germany, 53127
      Completed
      Site DE49016
      Lübeck, Germany, 23538
      Completed
      Site TR90007
      Ankara, Turkey, 06100
      Completed
      Site GR30004
      Athens, Greece, 11527
      Completed
      Site AT43003
      Linz, Austria, 4010
      Withdrawn
      Site RU70002
      Saint-Petersburg, Russian Federation, 197341
      Completed
      Site CH41002
      St. Gallen, Switzerland, 9007
      Completed
      Site GR30002
      Herakleion, Crete, Greece, 70013
      Completed
      Site ES34003
      Barakaldo, Vizcaya, Spain, 48903
      Completed
      Site IT39005
      Genova, Italy, 16132
      Completed
      Site PL48003
      Zgierz, Poland, 95-100
      Withdrawn
      Site RU70005
      Smolensk, Russian Federation, 214018
      Completed
      Site IT39007
      Napoli, Italy, 80131
      Withdrawn
      Site GB44012
      Harrogate, United Kingdom, HG2 7SX
      Completed
      Site HU36004
      Bekescsaba, Hungary, H-5600
      Completed
      Site RO40002
      Lasi, Romania, 700116
      Completed
      Site ES34006
      Valencia, Spain, 46026
      Completed
      Site AT43002
      Graz, Austria, 8020
      Completed
      Site IT39010
      Torino, Italy, 10154
      Completed
      Site GB44006
      Bristol, UK, United Kingdom, BS2 8HW
      Completed
      Site BE32001
      Brussels, Belgium, 1000
      Completed
      Site PT35107
      Vila Real, Portugal, 5000-508
      Completed
      Site IE35302
      Dublin, Ireland, 8
      Withdrawn
      Site NO47001
      Fredrikstad, Norway, 1603
      Completed
      Site TR90005
      Istanbul, Turkey, 34662
      Completed
      Site ES34004
      Barcelona, Spain, 08035
      Completed
      Site TR90003
      Adana, Turkey, 01330
      Completed
      Site DE49011
      Köln, Germany, 51067
      Completed
      Site GR30005
      Athens, Greece, 10675
      Withdrawn
      Site RU70004
      Samara, Russian Federation, 443079
      Completed
      Site GR30001
      Athens, Greece, 11527
      Completed
      Site HR38505
      Zadar, Croatia, 23 000
      Completed
      Site PT35104
      Vila Nova de Gaia, Portugal, 4434-502
      Completed
      Site HU36001
      Debrecen, Hungary, H-4043
      Withdrawn
      Site IT39008
      Palermo, Italy, 90127
      Completed
      Site CZ42005
      Kyjov, Czech Republic, 69733
      Completed
      Site PL48004
      Gdynia, Poland, 81-348
      Completed
      Site AT43001
      Salzburg, Austria, 5020
      Completed
      Site FR33007
      Paris, France, 75012
      Completed
      Site PL48011
      Szczecin, Poland, 71-899
      Completed
      Site GR30010
      Thessaloniki, Greece, 546 36
      Completed
      Site CZ42004
      Opava, Czech Republic, 74601
      Completed
      Site CH41001
      Lugano, Ticino, Switzerland, CH-6903
      Completed
      Site SE46005
      Uppsala, Sweden, 75185
      Completed
      Site CZ42002
      Brno-Bohunice, Czech Republic, 62500
      Completed
      Site SI38603
      Murska Sobota, Slovenia, 9000
      Completed
      Site FI35802
      Turku, Finland, 20521
      Completed
      Site SE46001
      Lund, Sweden, 22185
      Withdrawn
      Site GB44004
      Great Yarmouth, United Kingdom, NR31 6LA
      Completed
      Site SE46004
      Jönköping, Sweden, 55185
      Completed
      Site IT39002
      Padova, Italy, 35128
      Completed
      Site DE49006
      Leipzig, Germany, 04103
      Completed
      Site IE35304
      Limerick, Ireland, V94 F858
      Completed
      Site CZ42003
      Praha 5, Czech Republic, 15006
      Completed
      Site FR33003
      Bordeaux, France, 33000
      Completed
      Site TR90006
      Eskisehir, Turkey, 26480
      Withdrawn
      Site SE46006
      Östersund, Sweden, 83183
      Completed
      Site TR90002
      Ankara, Turkey, 06100
      Completed
      Site TR90004
      Istanbul, Turkey, 34890
      Completed
      Site CH41004
      Zürich, Switzerland, 8006
      Withdrawn
      Site HR38502
      Zagreb, Croatia, 10000
      Completed
      Site SI38602
      Maribor, Slovenia, 2000
      Completed
      Site GB44008
      Blackpool, United Kingdom, FY3 8NR
      Completed
      Site RU70001
      Moscow, Russian Federation, 115478
      Completed
      Site PT35102
      Amadora, Portugal, 2720-276
      Completed
      Site SI38601
      Ljubljana, Slovenia, 1000
      Completed
      Site FR33001
      Paris, France, 75010
      Completed
      Site IT39006
      Roma, Italy, 00168
      Completed
      Site GR30007
      Athens, Greece, 14561
      Completed
      Site HR38503
      Rijeka, Croatia, 51000

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?